ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2022
S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021.
Abstract read
In one paragraph
Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection.Acta dermato-venereologica · 2023Trial
- Patient preferences and travel burden before radiotherapy for primary cutaneous lymphoma: baseline results from the S-MISR registry.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026Article
- Cutaneous T Cell Lymphoma: Targeting the Survival Network in Mycosis Fungoides and Sézary Syndrome.Cancers · 2026Review
- Immunopathogenesis of itch: an integrative framework for chronic pruritus.JID innovations : skin science from molecules to population health · 2026Review
- Advances in the Field of Cutaneous Malignancies: Background and Clinical Management.Journal of clinical medicine · 2026Article
- [Gemcitabine-induced toxic epidermal necrolysis in a patient with mycosis fungoides].Dermatologie (Heidelberg, Germany) · 2026Article
- The dual burden of a rare cancer: psychosocial impact of disease symptoms and unmet care needs in cutaneous T-cell lymphoma.Frontiers in psychology · 2026Article
- [Primary cutaneous B-cell lymphomas-an overview of established and novel aspects].Dermatologie (Heidelberg, Germany) · 2025Review
- Evaluating mogamulizumab in the treatment of primary cutaneous T-cell lymphoma.Immunotherapy · 2025Review
- Alopecia Mimicking Lichen Planopilaris in a Patient with Mycosis Fungoides.Skin appendage disorders · 2025Article
- Scalp Involvement in Primary Cutaneous Lymphomas-An Update on Clinical Presentation, Diagnostics, and Management.Cancers · 2025Review
- Practical recommendations for therapy and monitoring of mogamulizumab patients in Germany.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025Review
- Health-related quality of life in primary cutaneous B-cell lymphoma following local radiotherapy.JAAD international · 2024Article
- Nanopore Sequencing for T-Cell Receptor Rearrangement Analysis in Cutaneous T-Cell Lymphoma.Cancers · 2024Article
- Mogamulizumab and Concomitant Hypofractionated Low-Dose Total Skin Electron Beam Therapy (2 × 4 Gy) in Cutaneous T-Cell Lymphoma: Proof of Principle, Report of Two Cases.Current oncology (Toronto, Ont.) · 2024Article
- Proceedings from the First Onco Summit: LATAM Chapter, 19-20 May 2023, Rio de Janeiro, Brazil.Cancers · 2024Article
- Adrenal Insufficiency after Long-term use of Topical Glucocorticoids in Patients with Advanced Cutaneous T-cell Lymphomas: A Case Series.Acta dermato-venereologica · 2024Article
- JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature.Cancers · 2024Review
- International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies.Blood advances · 2023Observational
- [Eczema and its treatment in older adults].Dermatologie (Heidelberg, Germany) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Edgar DippelDepartment of Dermatology, Hospital Ludwigshafen, Germany.
Chalid AssafDepartment of Dermatology and Venereology, Helios Hospital Krefeld, Germany.
Jürgen C BeckerWest German Tumor Center, University Hospital Essen, Germany.
Michael von Bergwelt-BaildonDepartment I of Internal Medicine, University Hospital Cologne, Germany.
Sophie BernreiterDepartment of Dermatology, Hospital Ludwigshafen, Germany.
Antonio CozzioDepartment of Dermatology, Venereology and Allergology, Canton Hospital St. Gallen, Switzerland.
Hans T EichDepartment of Radiation Therapy and Radio-Oncology, University Hospital Münster, Germany.
Khaled ElsayadDepartment of Radiation Therapy and Radio-Oncology, University Hospital Münster, Germany.
Markus FollmannGerman Cancer Society, Berlin, Germany.
Stephan GrabbeDepartment of Dermatology, University Hospital Mainz, Germany.
Uwe HillenDepartment of Dermatology, University Hospital Essen, Germany.
Wolfram KlapperInstitute of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
Claus-Detlev KlemkeDepartment of Dermatology, Municipal Hospital of Karlsruhe, Academic Teaching Hospital for the University of Freiburg, Karlsruhe, Germany.
Carmen LoquaiDepartment of Dermatology, University Hospital Mainz, Germany.
Frank MeissDepartment of Dermatology and Venereology, University Hospital Freiburg, medical Faculty, Albert-Ludwigs University Freiburg, Germany.
Christina MitteldorfDepartment of Dermatology, Venereology and Allergology, University Hospital Göttingen, Germany.
Ulrike WehkampDepartment of Dermatology, Venereology and Allergology, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
Dorothee NashanDepartment of Dermatology, Dortmund Hospital GmbH, Dortmund, Germany.
Jan P NicolayDepartment of Dermatology, Venereology and Allergology, University Hospital Mannheim, Germany.
Ilske OschliesInstitute of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
Max SchlaakCharité - Universitätsmedizin Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
René StranzenbachDepartment of Dermatology, Venereology and Allergology, University Hospital at Ruhr University Bochum, Germany.
Rose MoritzDepartment for Dermatology, University Hospital Halle, Germany.
Christoph StollRehabilitation Hospital, Herzoghöhe Bayreuth, Germany.
Tibor VagDepartment of Nuclear Medicine, Technical University of Munich, Germany.
Michael WeichenthalDepartment of Dermatology, Venereology and Allergology, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
Marion WobserDepartment of Dermatology, Venereology and Allergology, University Hospital Würzburg, Germany.
Rudolf StadlerDepartment of Dermatology, Venereology, Allergology, and Phlebology, Johannes Wesling University Hospital Minden, University Hospital at Ruhr University Bochum, Germany.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Lymphoma, T-Cell, CutaneousSkin NeoplasmsHumans
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.